Functional gastrointestinal disorders in Canada: First population-based survey using Rome II criteria with suggestions for improving the questionnaire

Digestive Diseases and Sciences

Volumn 47, Issue 1, 2002, Pages 225-235

  Thompson, W G ^a   Irvine, E J ^b   Pare, P ^c   Ferrazzi, S ^d   Rance, L ^d  

^a UNIVERSITY OF OTTAWA   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d Janssen Ortho Inc   (Canada)

Author keywords

Functional gastrointestinal disorders; IBS questionnaire; Irritable bowel syndrome; Rome criteria; Rome I; Rome II

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; CANADA; DIGESTIVE SYSTEM FUNCTION DISORDER; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE;

ADOLESCENT; ADULT; ALGORITHMS; CANADA; COLONIC DISEASES, FUNCTIONAL; DATA COLLECTION; FEMALE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES;

EID: 0036147287     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013208713670     Document Type: Article

References (31)

1. Epidemiology of constipation (EPOC) Study in the United States: Relation of clinical subtypes to sociodemographic features
2. US householder survey of functional gastrointestinal disorders: Prevalence, sociodemography and health impact
3. Functional bowel disorders in apparently healthy people
4. Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction
5. Epidemiologie des troubles fonctionnels dans une population apparement saine
6. Functional gastrointestinal symptoms in a Wellington community sample
7. Functional bowel disorders in apparently healthy chinese people
8. Towards positive diagnosis of the irritable bowel
9. Symptoms of irritable bowel syndrome in a British urban community: Consulters and nonconsulters
10. Functional bowel disorders and functional abdominal pain
11. Functional bowel disease and functional abdominal pain
12. Appendix B. The Rome II modular questionnaire
13. Functional bowel disorders and functional abdominal pain
14. Patient self-reports in pharmacoeconomic studies: Their use and impact on on study validity
15. Predictive values of the Rome criteria for diagnosing irritable bowel syndrome
16. Efficacy and safety of alosetron in women with irritable bowel syndrome: A randomised, placebo-controlled trial
17. The partial 5HT4 agonist Tegaserod, improves abdominal discomfort/pain and normalizes altered bowel function in irritable bowel syndrome (IBS)
18. Altered rectal perception is a biological marker of patients with irritable bowel syndrome
19. Intergenerational transmission of gastrointestinal illness behavior
20. Diagnosing irritable bowel syndrome: Predictive value of the Rome criteria
21. Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria
22. Appendix A. Research diagnostic questions for functional gastrointestinal disorders
23. Irritable bowel syndrome defined by factor analysis
24. Existence of irritable bowel syndrome supported by factor analysis of symptoms in two community samples
25. Gender differences in irritable bowel symptoms
26. Evidence for the ambiguity of the word constipation: The role of irritable bowel syndrome
27. Demographic and dietary determinants of constipation in the US population
28. The road to Rome